Dr. Thatcher R. Heumann
Claim this profileVanderbilt University/Ingram Cancer Center
Studies Cancer
Studies Tumors
6 reported clinical trials
16 drugs studied
Area of expertise
1Cancer
Stage IV
Stage III
2Tumors
Stage IV
Affiliated Hospitals
Vanderbilt University/Ingram Cancer Center
Vanderbilt Breast Center At One Hundred Oaks
Clinical Trials Thatcher R. Heumann is currently running
Pre- and Post-Surgery Chemotherapy
for Gallbladder Cancer
This phase II/III trial compares the effect of adding chemotherapy before and after surgery versus after surgery alone (usual treatment) in treating patients with stage II-III gallbladder cancer. Chemotherapy drugs, such as gemcitabine and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving chemotherapy before surgery may make the tumor smaller; therefore, may reduce the extent of surgery. Additionally, it may make it easier for the surgeon to distinguish between normal and cancerous tissue. Giving chemotherapy after surgery may kill any remaining tumor cells. This study will determine whether giving chemotherapy before surgery increases the length of time before the cancer may return and whether it will increase a patient's life span compared to the usual approach.
Recruiting1 award Phase 2 & 315 criteria
Tinengotinib
for Bile Duct Cancer
This trial is testing an oral medication called Tinengotinib for patients with a specific type of bile duct cancer that has not responded to other treatments. The medication works by blocking a protein that helps cancer cells grow. The goal is to see if Tinengotinib can slow down or stop the cancer in these patients.
Recruiting2 awards Phase 3
More about Thatcher R. Heumann
Clinical Trial Related3 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Thatcher R. Heumann has experience with
- BAY 1895344
- Irinotecan Hydrochloride
- Topotecan Hydrochloride
- Atezolizumab
- Varlilumab
- Cobimetinib
Breakdown of trials Thatcher R. Heumann has run
Cancer
Solid Tumors
Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Thatcher R. Heumann specialize in?
Thatcher R. Heumann focuses on Cancer and Tumors. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Thatcher R. Heumann currently recruiting for clinical trials?
Yes, Thatcher R. Heumann is currently recruiting for 4 clinical trials in Nashville Tennessee. If you're interested in participating, you should apply.
Are there any treatments that Thatcher R. Heumann has studied deeply?
Yes, Thatcher R. Heumann has studied treatments such as BAY 1895344, Irinotecan Hydrochloride, Topotecan Hydrochloride.
What is the best way to schedule an appointment with Thatcher R. Heumann?
Apply for one of the trials that Thatcher R. Heumann is conducting.
What is the office address of Thatcher R. Heumann?
The office of Thatcher R. Heumann is located at: Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee 37232 United States. This is the address for their practice at the Vanderbilt University/Ingram Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.